Clinical Trial Update: A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes [Phase 3]

View source ↗

Summary

This clinical trial update concerns enicepatide (RO7795068) in a Phase 3 study for obesity/overweight with type 2 diabetes. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Enicepatide (Enicepatide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Obesity or Overweight, Type 2 Diabetes Mellitus | Phase 3 | Status: RECRUITING